Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Buclin

Showing results (1-10 of 250) with videos related to

Pageof 25
Sort By:
Revue Medicale Suisse|February 5, 2025
Thierry Buclin
Revue Medicale Suisse|June 11, 2013
[Prescribing monitoring in clinical practice: from enlightened empiricism to rational strategies]Thierry Buclin, Lilli Herzig
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?Eric Grouzmann, Thierry Buclin
Journal of Hepatology|September 8, 2015
Pharmacokinetics in hepatic impairment: Mind the protein bindingHaithem Chtioui, Thierry Buclin
Revue Medicale Suisse|November 8, 2019
[N-of-1 trials or single-patient therapeutic tests: evidence-based tests to diagnose therapeutic efficacy]Léonore Diezi, Thierry Buclin
Clinical Chemistry|October 1, 2008
Calibration of fractionated metanephrines in urine: still an issue?Eric Grouzmann, Bruno Mathian, Thierry Buclin
Revue Medicale Suisse|October 4, 2014
[New hepatitis C treatments: pharmacological considerations and potential for drug interactions]Haithem Chtioui, Thierry Buclin, Darius Moradpour
Therapeutic Drug Monitoring|September 11, 2012
Safe and effective variability-a criterion for dose individualizationNicholas H G Holford, Thierry Buclin
Pharmaceutics|June 27, 2024
Population Pharmacokinetics in Oncology and Its Clinical ApplicationsNicolas Widmer, Monia Guidi, Thierry Buclin
Revue Medicale Suisse|September 5, 2008
[Pharmacogenetic testing: soon before every prescription?]Thierry Buclin, Sara Colombo, Jérôme Biollaz
Pageof 25

Showing results (1-10 of 250) with videos related to

Sort By:
Pageof 25
Revue Medicale Suisse|February 5, 2025
Thierry Buclin
Revue Medicale Suisse|June 11, 2013
[Prescribing monitoring in clinical practice: from enlightened empiricism to rational strategies]Thierry Buclin, Lilli Herzig
Hypertension (Dallas, Tex. : 1979)|November 21, 2007
Is dipeptidylpeptidase IV the missing link in angiotensin-converting enzyme inhibitor--induced angioedema?Eric Grouzmann, Thierry Buclin
Journal of Hepatology|September 8, 2015
Pharmacokinetics in hepatic impairment: Mind the protein bindingHaithem Chtioui, Thierry Buclin
Revue Medicale Suisse|November 8, 2019
[N-of-1 trials or single-patient therapeutic tests: evidence-based tests to diagnose therapeutic efficacy]Léonore Diezi, Thierry Buclin
Clinical Chemistry|October 1, 2008
Calibration of fractionated metanephrines in urine: still an issue?Eric Grouzmann, Bruno Mathian, Thierry Buclin
Revue Medicale Suisse|October 4, 2014
[New hepatitis C treatments: pharmacological considerations and potential for drug interactions]Haithem Chtioui, Thierry Buclin, Darius Moradpour
Therapeutic Drug Monitoring|September 11, 2012
Safe and effective variability-a criterion for dose individualizationNicholas H G Holford, Thierry Buclin
Pharmaceutics|June 27, 2024
Population Pharmacokinetics in Oncology and Its Clinical ApplicationsNicolas Widmer, Monia Guidi, Thierry Buclin
Revue Medicale Suisse|September 5, 2008
[Pharmacogenetic testing: soon before every prescription?]Thierry Buclin, Sara Colombo, Jérôme Biollaz
Pageof 25